Cargando…

Severe Infusion Reactions to Cetuximab Occur within 1 h in Patients with Metastatic Colorectal Cancer: Results of a Nationwide, Multicenter, Prospective Registry Study of 2126 Patients in Japan

OBJECTIVE: Infusion reactions are common adverse reactions associated with antibody preparations. However, no studies have examined the time to onset of serious infusion reactions after administering cetuximab. We aimed to investigate the timing and severity of IRs affecting Japanese patients after...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamaguchi, Kensei, Watanabe, Toshiaki, Satoh, Taroh, Ishiguro, Megumi, Izawa, Makiko, Inoshiri, Shogo, Sugihara, Kenichi, Sakata, Yuh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033604/ https://www.ncbi.nlm.nih.gov/pubmed/24771864 http://dx.doi.org/10.1093/jjco/hyu049

Ejemplares similares

Incidence and Clinical Features of Drug-induced Lung Injury in Patients with Advanced Colorectal Cancer Receiving Cetuximab: Results of a Prospective Multicenter Registry
por: Satoh, Taroh, et al.
Publicado: (2014)

A Japanese Post-marketing Surveillance of Cetuximab (Erbitux(®)) in Patients with Metastatic Colorectal Cancer
por: Ishiguro, Megumi, et al.
Publicado: (2012)

Encorafenib, binimetinib, and cetuximab in BRAF V600E–mutated colorectal cancer: an early post-marketing phase vigilance study
por: Sakata, Hidenori, et al.
Publicado: (2022)

A First Insight into Pycnoporus sanguineus BAFC 2126 Transcriptome
por: Rohr, Cristian O., et al.
Publicado: (2013)

Allergic/infusion reactions reported with cetuximab and rituximab
por: Wolf, Ray A, et al.
Publicado: (2015)

2126 Optimizing a technique for visualizing retinal and choroidal blood flow noninvasively
por: Vora, Paras, et al.
Publicado: (2018)

PB2126: RETROSPECTIVE REAL LIFE STUDY OF MULTIPLE MYELOMA STATUS AT DEATH.
por: Pérez, Mónica Fernández, et al.
Publicado: (2023)

Adenylylation of small RNA sequencing adapters using the TS2126 RNA ligase I
por: Lama, Lodoe, et al.
Publicado: (2016)

Background mutation in strain RB2126 affects the locomotion behavior of flp-1 mutants
por: Topalidou, Irini
Publicado: (2021)

BIG BANG study (EPOC1703): multicentre, proof-of-concept, phase II study evaluating the efficacy and safety of combination therapy with binimetinib, encorafenib and cetuximab in patients with BRAF non-V600E mutated metastatic colorectal cancer
por: Kotani, Daisuke, et al.
Publicado: (2020)

Combined Analysis of Plasma Amphiregulin and Heregulin Predicts Response to Cetuximab in Metastatic Colorectal Cancer
por: Yonesaka, Kimio, et al.
Publicado: (2015)

High incidence of cetuximab-related infusion reactions in head and neck patients
por: Palomar Coloma, Virginia, et al.
Publicado: (2018)

Management of infusion reactions associated with cetuximab treatment: A case report
por: Ohshita, Naohiro, et al.
Publicado: (2017)

Demographic, signs and symptoms, imaging characteristics of 2126 patients with COVID-19 pneumonia in the whole quarantine of Wuhan, China
por: Yin, Xi, et al.
Publicado: (2021)

Clinical and economic impact of infusion reactions in patients with colorectal cancer treated with cetuximab
por: Foley, K. A., et al.
Publicado: (2010)

PReS-FINAL-2126: How to follow up children with Raynaud syndrome - recommendations based on the Hamburg consensus meeting 2012
por: Constantin, T, et al.
Publicado: (2013)

HER2 genomic amplification in circulating tumor DNA from patients with cetuximab-resistant colorectal cancer
por: Takegawa, Naoki, et al.
Publicado: (2015)

2126. Comparison of Time to Appropriate Antibiotic Between Using Microarray Assay and Mass Spectrometry Technique for Identification of Positive Blood Cultures
por: Sakulkonkij, Parichart, et al.
Publicado: (2019)

Operating assignments in endocrine surgery training among 2126 resident participations and the Covid-19 impact: A retrospective cohort study()
por: Sarıdemir Ünal, Demet, et al.
Publicado: (2023)

Overexpression of the S100A2 protein as a prognostic marker for patients with stage II and III colorectal cancer
por: MASUDA, TAIKI, et al.
Publicado: (2016)

Observational study of first-line chemotherapy including cetuximab in patients with metastatic colorectal cancer: CORAL trial
por: Muro, Kei, et al.
Publicado: (2019)

Incidence of cetuximab-related infusion reaction in head and neck cancer patients: may we predict it?
por: Merlano, Marco C, et al.
Publicado: (2018)

Retrospective analysis of premedication, glucocorticosteroids, and H(1)-antihistamines for preventing infusion reactions associated with cetuximab treatment of patients with head and neck cancer
por: Ikegawa, Kiwako, et al.
Publicado: (2017)

Erratum. Psychosocial Care for People With Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care 2016;39:2126–2140
por: Young-Hyman, Deborah, et al.
Publicado: (2017)

2126. Comparative Effectiveness of Infection Prevention Interventions for Reducing Procedure-Related Cardiac Device Infections: Insights from the VA CART Program
por: Asundi, Archana, et al.
Publicado: (2018)

Erratum. Psychosocial Care for People With Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care 2016;39:2126–2140
por: Young-Hyman, Deborah, et al.
Publicado: (2017)

Utility of Serum EB Virus Zta Antibody in the Diagnostic of Nasopharyngeal Carcinoma: Evidences From 2,126 Cases and 15,644 Controls
por: Zhang, Guangying, et al.
Publicado: (2019)

PB2126: R-CPOP AS FIRST LINE TREATMENT FOR DLBCL PATIENTS WITH SIGNIFICANT REDUCED LVEF OR HIGH RISK OF ANTHRACYCLINE INDUCED CARDIOTOXICITY
por: Lorenz, K., et al.
Publicado: (2022)

Prognostic significance of Traf2- and Nck- interacting kinase (TNIK) in colorectal cancer
por: Takahashi, Hidenori, et al.
Publicado: (2015)

S-1 and oxaliplatin (SOX) plus bevacizumab versus mFOLFOX6 plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer: updated overall survival analyses of the open-label, non-inferiority, randomised phase III: SOFT study
por: Baba, Hideo, et al.
Publicado: (2017)

A retrospective analysis of cross-reacting cetuximab IgE antibody and its association with severe infusion reactions
por: Maier, Sabine, et al.
Publicado: (2015)

Successful rechallenge with cetuximab after an infusion related reaction to panitumumab in a patient with locally advanced rectal cancer
por: Yokokawa, Hideyuki, et al.
Publicado: (2020)

Transient Central Diabetes Insipidus Occurring After Vasopressin Infusion
por: Cristiano, Elizabeth A., et al.
Publicado: (2021)

Clinical Validation of a Multiplex Kit for RAS Mutations in Colorectal Cancer: Results of the RASKET (RAS KEy Testing) Prospective, Multicenter Study
por: Yoshino, Takayuki, et al.
Publicado: (2015)

Interstitial lung disease occurring shortly after tocilizumab infusion in a patient with polyarticular juvenile idiopathic arthritis: a case report
por: Sugihara, Koichi, et al.
Publicado: (2021)

Isolation and characterization of a thermostable RNA ligase 1 from a Thermus scotoductus bacteriophage TS2126 with good single-stranded DNA ligation properties
por: Blondal, Thorarinn, et al.
Publicado: (2005)

Phase II trial of biweekly cetuximab and irinotecan as third‐line therapy for pretreated KRAS exon 2 wild‐type colorectal cancer
por: Osumi, Hiroki, et al.
Publicado: (2018)

Acute Pancreatitis Occurring after Pamidronate Infusions in Two Patients with Spondyloarthritis
por: Toussirot, Éric, et al.
Publicado: (2013)

Comment on Young-Hyman et al. Psychosocial Care for People With Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care 2016;39:2126–2140
por: Mezuk, Briana, et al.
Publicado: (2017)

2126. Safety, Tolerability, and Pharmacokinetics (PK) in Healthy Participants Following Single Dose Administration of Zosurabalpin, a Novel Pathogen-Specific Antibiotic for the Treatment of Serious Acinetobacter Infections
por: Guenther, Andreas, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kml381fgjc1epn1vhchme4iag6